Microsaic Systems PLC
LSE:MSYS
Microsaic Systems PLC
Microsaic Systems Plc engages in the research, development, and commercialization of scientific instruments. The company is headquartered in Woking, Surrey and currently employs 21 full-time employees. The company went IPO on 2011-04-11. The firm operates through the research, development and commercialization of scientific instruments segment. The firm is engaged in developing and marketing chip-based mass spectrometry (MS) instruments. Its chip-based MS technology enables point-of-need detection at any stage in a user’s workflow, which is designed for the pharmaceutical and biopharmaceutical industries. Its compact MS systems and software deliver processing and manufacturing agility, as well as commercial productivity. Its chip-based technology enables analytical detection and characterization within a conventional laboratory setting, or within a bioprocessing facility. The Company’s mass spectrometer detection enables users to make decisions to adjust, optimize and control their processes in real-time. The company offers MiDas compact sampling interface, which allows automated sampling, dilution and injection for direct mass spectrometer analysis.
Microsaic Systems Plc engages in the research, development, and commercialization of scientific instruments. The company is headquartered in Woking, Surrey and currently employs 21 full-time employees. The company went IPO on 2011-04-11. The firm operates through the research, development and commercialization of scientific instruments segment. The firm is engaged in developing and marketing chip-based mass spectrometry (MS) instruments. Its chip-based MS technology enables point-of-need detection at any stage in a user’s workflow, which is designed for the pharmaceutical and biopharmaceutical industries. Its compact MS systems and software deliver processing and manufacturing agility, as well as commercial productivity. Its chip-based technology enables analytical detection and characterization within a conventional laboratory setting, or within a bioprocessing facility. The Company’s mass spectrometer detection enables users to make decisions to adjust, optimize and control their processes in real-time. The company offers MiDas compact sampling interface, which allows automated sampling, dilution and injection for direct mass spectrometer analysis.
